Company Analysis Sanofi
1. Summary
Advantages
- Dividends (3.77%) are higher than the sector average (0.5261%).
- Current debt level 13.48% is below 100% and has decreased over 5 years from 22.15%.
Disadvantages
- Price (50.83 $) is higher than fair price (23.44 $)
- The stock's return over the last year (-9.76%) is lower than the sector average (0%).
- The company's current efficiency (ROE=7.34%) is lower than the sector average (ROE=14.17%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Sanofi | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0.7% | -0.2% | -0.3% |
| 90 days | -0.7% | -0.8% | 10% |
| 1 year | -9.8% | 0% | 9.7% |
SNY vs Sector: Sanofi has significantly underperformed the "Healthcare" sector by -9.76% over the past year.
SNY vs Market: Sanofi has significantly underperformed the market by -19.49% over the past year.
Stable price: SNY is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: SNY with weekly volatility of -0.1878% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (50.83 $) is higher than the fair price (23.44 $).
Price is higher than fair: The current price (50.83 $) is 53.9% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (20.89) is lower than that of the sector as a whole (63.23).
P/E vs Market: The company's P/E (20.89) is lower than that of the market as a whole (89.86).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.49) is lower than that of the sector as a whole (18.83).
P/BV vs Market: The company's P/BV (1.49) is lower than that of the market as a whole (9.35).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.62) is lower than that of the sector as a whole (32.67).
P/S vs Market: The company's P/S indicator (2.62) is lower than that of the market as a whole (10.1).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (11.48) is lower than that of the sector as a whole (274.42).
EV/Ebitda vs Market: The company's EV/Ebitda (11.48) is lower than that of the market as a whole (50.71).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -10.95% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-10.95%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-15.75%).
5.4. ROE
ROE vs Sector: The company's ROE (7.34%) is lower than that of the sector as a whole (14.17%).
ROE vs Market: The company's ROE (7.34%) is lower than that of the market as a whole (11.64%).
5.5. ROA
ROA vs Sector: The company's ROA (4.29%) is higher than that of the sector as a whole (1.18%).
ROA vs Market: The company's ROA (4.29%) is lower than that of the market as a whole (6.88%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (7.32%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (7.32%) is lower than that of the market as a whole (11%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 3.77% is higher than the average for the sector '0.5261%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 3.77% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 3.77% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (84.6%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
